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Abstract
Gambiense human African trypanosomiasis (gHAT) is a virulent disease declining in
burden but still endemic in West and Central Africa. Although it is targeted for
elimination of transmission by 2030, there remain numerous questions about the drivers
of infection and how these vary geographically.
In this study we focus on the Democratic Republic of Congo (DRC), which
accounted for 84% of the global case burden in 2016, to explore changes in transmission
across the country and elucidate factors which may have contributed to the persistence
of disease or success of interventions in different regions. We present a Bayesian fitting
methodology, applied to 168 endemic health zones (∼100,000 population size), which
allows for calibration of a mechanistic gHAT model to case data (from the World Health
Organization HAT Atlas) in an adaptive and automated framework.
It was found that the model needed to capture improvements in passive detection to
match observed trends in the data within former Bandundu and Bas Congo provinces
indicating these regions have substantially reduced time to detection. Health zones in
these provinces generally had longer burn-in periods during fitting due to additional
model parameters.
Posterior probability distributions were found for a range of fitted parameters in each
health zone; these included the basic reproduction number estimates for pre-1998 (R0)
which was inferred to be between 1 and 1.14, in line with previous gHAT estimates, with
higher median values typically in health zones with more case reporting in the 2000s.
Previously, it was not clear whether a fall in active case finding in the period
contributed to the declining case numbers. The modelling here accounts for variable
screening and suggests that underlying transmission has also reduced greatly – on
average 96% in former Equateur, 93% in former Bas Congo and 89% in former
Bandundu – Equateur and Bandundu having had the highest case burdens in 2000.
This analysis also sets out a framework to enable future predictions for the country.
November 13, 2020 1/25
Author summary
Gambiense human African trypanosomiasis (gHAT; sleeping sickness) is a deadly disease
targeted for elimination of transmission by 2030, however there are still several
unknowns about what factors influence continued transmission and how this changes
with geographic location.
In this study we focus on the Democratic Republic of Congo (DRC), which reported
84% of the global cases in 2016 to try and explain why some regions of the country have
had more success than others in bringing down case burden. To achieve this we used a
state-of-the-art statistical framework to match a mathematical gHAT model to reported
case data for 168 regions with some case reporting during 2000–2016.
The analysis indicates that two former provinces, Bandundu and Bas Congo had
substantial improvements to case detection in fixed health facilities in the time period.
Overall, all provinces were estimated to have reductions in (unobservable) transmission
including ∼96% in former Equateur. This is reassuring as case finding effort has
decreased in that region.
The model fitting presented here will allow predictions of gHAT under alternative
intervention strategies to be performed in future studies.
Introduction 1
Gambiense human African trypanosomiasis (gHAT) is a disease caused by the protozoan 2
parasite Trypanosoma brucei gambiense which is transmitted by tsetse. The disease has 3
two distinct stages during which the disease progresses from mild to severe, and can 4
lead to death without treatment. 5
gHAT occurs throughout Western and Central Africa, with 15 countries reporting 6
new cases in the period 2000–2016 [1]. The majority of the detected gHAT cases are in 7
the Democratic Republic of Congo (DRC) where 84% of the new cases in 2016 were 8
reported [2]. While these cases are predominantly in the former province of Bandundu, 9
they are widespread across this large country (230 of 516 health zones had reported 10
cases between 2012 and 2016). 11
It has long been understood that treatment of gHAT patients not only prevents 12
excess mortality but it can also reduce the time spent infectious, and thereby reduce 13
onward transmission in the population. A combination of active screening and passive 14
surveillance followed by treatment of cases has resulted in a decline in the number of 15
new cases from 25,841 (16,951 in DRC) in 2000 to 2,110 (1,768 in DRC) in 2016 [1]. 16
During this time period both diagnostics and drugs for gHAT have evolved with vast 17
improvements for patients. 18
Traditional active screening of at-risk populations is done by mobile teams visiting 19
villages and performing an initial mass screen using serological tools (usually the card 20
agglutination test for trypanosomes - CATT), followed by microscopy for serologically 21
positive suspects to confirm presence of the parasite. This microscopic parasitological 22
confirmation of a case was required before drug administration. For the treatments 23
available in the previous two decades, a final “staging” test – a lumbar puncture to 24
establish whether a patient has trypanosomes or elevated white blood cell count in 25
cerebrospinal fluid – was required to select appropriate treatment. This necessary, 26
multi-step diagnostic pathway currently precludes the possibility of mass drug 27
administration as used in control programmes for other neglected tropical diseases 28
(NTDs). 29
For infected people who evade detection by active screening due to imperfect 30
diagnostics, non-attendance in active screening, or whose village is not screened, it is 31
possible for them to self-present at fixed health facilities and be diagnosed through 32
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passive surveillance. Not all fixed health facilities have gHAT diagnostics but this has 33
been improved over the last 20 years. Globally, WHO estimate that in 2012, 41%, 71%, 34
and 83% of at-risk population lived within 1, 3 and 5 hours of health facilities with 35
these diagnostics respectively [3], and by 2017 this increased to 58%, 79%, 89% [1]. It is 36
not clear what quantitative impact this improvement has had on time to detection. 37
Along with many other NTDs, gHAT is the subject of two World Health 38
Organisation goals; for gHAT these are (1) elimination as a public health problem by 39
2020 and (2) elimination of transmission (EOT) by 2030. If we are to truly strive to 40
reach this second elimination of transmission goal, then it is of utmost importance to 41
understand and quantify the reasons for success to date (indeed, it is expected that we 42
are on track for the first goal [1] with some countries identified as eligible for validation 43
of gHAT elimination as a public health problem in the latest WHO report [4]), and 44
identify what factors may have hindered progress. 45
gHAT transmission is known to be highly focal - now burden of disease is decreasing 46
globally, there remain pockets of infection in geographically disconnected areas [1]. 47
Previous mathematical modelling work has shown that, whilst persistence of infection at 48
very low prevalences is generally surprising for infectious diseases, the slow progression 49
of gHAT in individuals enables this infection to remain extant for long periods of time 50
in small settlements [5]. Other transmission modelling has examined drivers of gHAT in 51
specific foci and concluded that, by fitting to longitudinal human case data, there must 52
exist heterogeneity in risk of humans populations both in terms of exposure to tsetse 53
and also in participation in active screening [6, 7]. Other factors which are likely to vary 54
geographically include access to fixed health facilities with gHAT diagnostics - this can 55
impact the time individuals spend infected and the risk that they die without diagnosis - 56
and the regional density of tsetse. At present it is, however, unknown which drivers are 57
influencing transmission in different regions. 58
In the present study we consider what epidemiological variables are driving 59
transmission across the health zones (∼ 100,000 population size) of DRC using a 60
dynamic transmission model, and examine how control interventions from 2000 to 2016 61
have impacted infection and modified some of these variables over time. To achieve 62
parameter estimation across the country we utilise an automated Bayesian fitting 63
procedure with an adaptive Metropolis-Hastings random walk and in-built convergence 64
diagnostics. The samples from the posterior probability distributions of fitted 65
parameters from this method can be used to examine within health zone parameter 66
averages and uncertainty as well as comparing estimates across health zones. The 67
mechanistic model can be used to infer the level of transmission to humans over time 68
even though it is not directly observable in data; the posterior parameters are used to 69
do this. 70
There are three major outputs from this study. Firstly, the parameterisation of our 71
gHAT transmission model which allows future predictions to be made considering 72
different gHAT intervention strategies [8]. With future predictions based on realistic, 73
localised epidemiological parameters; economic evaluations of the cost-effectiveness of 74
different approaches to the control of gHAT are possible [9]. Secondly, the evaluation of 75
the effectiveness of interventions against gHAT in DRC across the period 2000 to 2016. 76
Lastly, but potentially of most value to our research going forwards, the provision of a 77
rapid, repeatable model fitting framework to facilitate future research around the model 78
presented here and other variants of it. 79
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Materials and methods 80
Data 81
Data on gHAT cases in DRC were obtained from the WHO who curate the global HAT 82
Atlas database [1, 10,11]. The data in the HAT Atlas are case data aggregated by 83
location, year and surveillance type. Location was defined by the available geolocation 84
and geographical identifier information, while surveillance type was either active or 85
passive screening. There were 117,573 records in the HAT Atlas data file covering the 86
period 2000–2016. Although many data entries for 2015 and 2016 have information of 87
the stage (1 or 2) of disease, very little staging information was available prior to 2015. 88
Because administrative areas may be redefined or renamed over time, the HAT Atlas 89
records were matched to a single, recent map obtained as a shapefile (UCLA, personal 90
communication). Matching to the shapefile was performed by geolocation, where 91
available, plus an identifier matching both to geolocated locations and directly to the 92
administrative areas stored in the shapefile. Other geographical data were sourced from 93
the Humanitarian Data Exchange – an older United Nations Office for the Coordination 94
of Humanitarian Affairs (OCHA) health zone shapefile, and geolocations of localities 95
(OCHA) and health facilities (Global Healthsite Mapping Project) within DRC. The 96
additional geographical data provided alternative names for administrative/health areas 97
as well as names and geolocations of locations and hence facilitate the data cleaning and 98
matching process. While geolocations (longitude and latitude) were available for most 99
records they may not be reliable indicators of position as they may have been assigned 100
as the centroid of the lowest available level administrative/health area if not recorded 101
directly. A standardisation procedure was performed on area and location names from 102
all sources. Sequential matching was then carried out, with unmatched records being 103
carried forward to the next step. The location and health site lists were combined and 104
located on the UCLA shapefile to obtain administrative area names consistent with this 105
map. Detail on this process is available in the Supplementary Information (S1 Materials 106
and Methods). 107
Following data matching, the data were aggregated within health zone, year and 108
surveillance type to produce health zone level data sets for all health zones in which 109
cases were reported. It is noted that for a small number of health zone–year 110
combinations the reported number of cases detected by active screening was more than 111
the declared number of people screened, which was zero in some instances. 112
Cases of gHAT are not recorded across all of the DRC; for many regions this is 113
because they have not historically observed gHAT cases and are not believed to be 114
endemic for gHAT, but for others it is due to challenging accessibility. Fig 1 shows the 115
regions where there were no data as well as the status of the analysis performed in the 116
present study. Inference was not performed for all health zones where there were data 117
available; either because there were too few observations (Data < 10), no cases were 118
detected (No Detections) or because transmission is believed not to be taking place, 119
since there is an absence of tsetse habitat (No Transmission). Inference was deemed to 120
be possible where there were 10 or more observations, where an observation was an 121
aggregate record for a single year relating to either more than 20 people being actively 122
screened or cases detected passively. 123
Fig 2 contains three maps of aggregated numbers of new cases by health zone for 124
three non-consecutive five-year periods spanning the period 2000–2016 for which data 125
were available. These maps illustrate the decrease in cases reported over time, in 126
particular in the former provinces of Equateur (in the North-West of DRC), which had 127
the highest burden in 2000, and Bandundu (situated to the east of Kinshasa), which 128
despite its decrease is now the most highly-endemic region globally. In the North there 129
was an increase in reported cases due to the presence of Médecins Sans Frontières (MSF) 130
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Urban Kinshasa
Analysis status
Data < 10
No Data
No Detections
No Transmission
Inference performed
Fig 1. Status of the individual health zone-level analyses, if the analysis was not run
the reason is indicated.
who use an alternative diagnostic algorithm to that used by the national programme. 131
The MSF algorithm did not feature parasitological confirmation after serological testing, 132
and hence had a higher sensitivity but lower specificity (similar to those described 133
in [12]). Some cases were reported in urban Kinshasa (Fig 2), however these are 134
believed to be the result of infections that occurred elsewhere and there is assumed to 135
be no transmission within urban Kinshasa (Fig 1) and hence no model fitting was 136
performed for those health zones. 137
Model 138
gHAT infection model 139
The deterministic gHAT model equations are ordinary differential equations given in Eq 140
(1) and correspond to the model schematic presented in Fig 3. The model is the variant 141
“Model 4” of that presented elsewhere [6, 7, 13–16]: in this model variant human hosts 142
are assumed to be either at low-risk and randomly participate in screening (subscript 143
H1), or high-risk and never participate in screening (subscript H4). Equation (1) 144
therefore uses indices to denote the risk classes, using only i ∈ {1, 4}, with other 145
subscripts being reserved for model variants with high-/low-risk structures as presented 146
in other publications [6,7] but not considered here. In Model 4, tsetse bites are assumed 147
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Kinshasa
Urban
Kinshasa
2000−2004: 68,478 cases 2006−2010: 35,210 cases 2012−2016: 17,868 cases
0 50 800 4000
Fig 2. Total number of new cases recorded within health zone and five-year period.
to be taken on humans or non-reservoir animals, however, the non-reservoir animal 148
species do not need to be explicitly modelled. Infection occurring in animals is not 149
modelled in the present study. 150
For simplicity we consider a closed population of size NH individuals, with natural 151
mortality and births. Furthermore, we assume that any deaths related to gHAT will be 152
replaced by new susceptibles entering the population, therefore the parameter γH 153
represents a mix of disease-induced deaths and detection in stage 2. To compute the 154
cases found in stage 2 passive detection we multiple the reporting rate u by the stage 2 155
exit rate γH . As we only expect disease-induced deaths from stage 2 infection, the same 156
does not apply to the stage 1 detection rate. 157
The model is parameterised with a combination of fixed and fitted parameters. 158
Fixed parameters (see Table 1) generally correspond to assumed biological values that 159
are unlikely to vary across the DRC, such as the human mortality rate (µH), tsetse bite 160
rate (α) and stage 1 to stage 2 disease progression in humans (ϕH). Fitted parameters 161
(see Table 2) are those which are likely to be correlated with region including the 162
proportion of the population at low-risk of infection (k1), the relative rate at which 163
high-risk humans are bitten by tsetse (r), the reporting rate (u) (corresponding to 164
access to health facilities with gHAT testing capacity), and parameters linked to the 165
time to passive detection or disease-induced mortality (ηH for stage 1 and γH for stage 166
2). Some parameters of the model are not fitted themselves but are functions of other 167
parameters. The proportion of high-risk people in the population was calculated as 168
k4 = 1− k1. The exit rate from stage 2 pre-1998 was assumed to be less than that 169
achieved post-1998, and was therefore calculated as γpreH = bγpreH γ
post
H , where γ
post
H was 170
the treatment rate from stage 2 post-1998 and bγpreH is a fitted value in the range zero to 171
one. The tsetse-to-human relative density, meff, is calculated from R0 using the next 172
generation matrix approach. 173
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Table 1. Model parameterisation (fixed parameters). Notation, a brief
description, and the values used for fixed parameters.
Notation Description Value
NH Total human population size
in 2015
Fixed for each health zone [17]
µH Natural human mortality rate 5.4795×10−5 days−1 [18]
BH Total human birth rate = µHNH
σH Human incubation rate 0.0833 days
−1 [19]
ϕH Stage 1 to 2 progression rate 0.0019 days
−1 [20, 21]
ωH Recovery rate or waning-
immunity rate
0.006 days−1 [22]
Sens Active screening diagnostic
sensitivity
0.91 [12]
BV Tsetse birth rate (per capita
rate of depositing new pupae)
0.0505 days−1 [13]
ξV Rate of pupal development to
adult flies
0.037 days −1
K Pupal carrying capacity = 111.09NH [13]
P(pupating) Probability of a pupa surviv-
ing to emerge as an adult fly
0.75
µV Tsetse mortality rate 0.03 days
−1 [19]
σV Tsetse incubation rate 0.034 days
−1 [23, 24]
α Tsetse bite rate 0.333 days−1 [25]
pV Probability of tsetse infection
per single infective bite
0.065 [19]
ε Reduced susceptibility factor
for non-teneral (previously
fed) flies
0.05 [6]
fH Proportion of blood-meals on
humans
0.09 [26]
dispact Overdispersion parameter for
active detection
4× 10−4 –
disppass Overdispersion parameter for
passive detection
2.8× 10−5 –
The value of BV was chosen to maintain constant population size in the absence of vector control
interventions. The value of K was chosen to reflect the observed bounce back rate.
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Table 2. Model parameterisation (fitted parameters). Notation, brief description, and information on the prior
distributions for fitted parameters.
Notation Description Prior distribution1 Percentiles of
prior distribution
[2.5, 50 & 97.5%]
Unit
R0 Basic reproduction
number
(NGM approach)
1 + Exp(10) [1.003, 1.069, 1.369] -
r Relative bites taken on
high-risk humans
1 + Γ(3.68, 1.09) [2.015, 4.654, 10.028] -
k1 Proportion of low-risk
people
B(16.97, 3.23) [0.6564, 0.8514, 0.9609] -
ηpostH
2 Treatment rate from
stage 1, 1998 onwards
Γ
(
3.54, 5.32× 10−5
)
[4.59, 17.1, 42.9]×10−5 days−1
γpostH
2 Combined treatment
and disease-induced
death rate from stage
2, 1998 onwards
Γ(2.45, 0.00192) [7.59, 40.7, 121]×10−4 days−1
bγpreH Relative treat-
ment/death rate
from stage 2 factor,
pre-1998
B(1, 1) [0.025, 0.500, 0.975] -
Spec Active screening diag-
nostic specificity
0.998 + (1− 0.998) B(7.23, 2.41) [0.9989, 0.9995, 0.9999] -
u Proportion of stage 2
passive cases reported
B(20, 40) [0.2208, 0.3315, 0.4564] -
dchange
3 Midpoint year for pas-
sive improvement
2000 + (2017− 2000) B(5, 6) [2003.2, 2007.7, 2012.5] Year
ηHamp
4 Relative improvement
in passive stage 1 detec-
tion rate
Γ(2.013, 1.049) [0.258, 1.775, 5.870] -
γHamp
4 Relative improvement
in passive stage 2 detec-
tion rate
Γ(1.001, 5) [0.127, 3.471, 18.455] -
dsteep
4 Speed of improvement
in passive detection
rate
Γ(39.57, 0.0270) [0.761, 1.058, 1.424] years−1
1Where Exp(.), Γ(.) and B(.) are the exponential, gamma (parameterised with shape and scale) and beta distributions, respectively.
2Former province-specific priors used for ηpostH and γ
post
H ; prior distributions and percentiles for Bandundu presented, see SI “S1 Materials
and Methods” for other former provinces. 3dchange is only fitted in the former province of Bandundu.
4ηHamp , γHamp and dsteep are only
fitted in the former provinces of Bandundu and Bas Congo; the prior distributions and percentiles presented relate to Bandundu, see SI
“S1 Materials and Methods” for Bas Congo.
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SH1 EH1 I1H1 I2H1 RH1
SH4 EH4 I1H4 I2H4 RH4
PV
SV
EV
GV
IV
Non-
reservoir
animals
λH1
ξV
σH ϕH γH(Y )
ηH(Y )
λH4 σH ϕH γH(Y )
ηH(Y )
λV
α− λV
ελV
σV
ωH
ωH
BH1
BH4
BV
low-risk
humans
high-risk
humans
tsetse
Fig 3. Illustration of compartmental gHAT model. Multi-host model of gHAT
with one host species able to confer T. b. gambiense (humans), a further non-reservoir
species and tsetse. After a short incubation period, infected human hosts follow the
progression which includes an infectious stage 1 disease, I1H , infectious stage 2 disease,
I2H , and a hospitalised/recovering class, R. Pupal stage tsetse, PV , emerge into unfed
adults. Unfed tsetse are susceptible, SV , and following a blood-meal become either
exposed, EV , or have reduced susceptibility to the trypanosomes with subsequent
bloodmeals, GV . Tsetse select their blood-meal from one of the host types dependant
upon innate feeding preference and relative host abundance. High-risk humans are
r-fold more likely to receive bites than low-risk humans. Any blood-meals taken upon
non-reservoir animals do not result in infection. The transmission of infection between
humans and tsetse is shown by grey paths. This figure is adapted from the original
model schematic [6].
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Humans

dSHi
dt
= µHNHi + ωHRHi − αmefffi
SHi
NHi
IV − µHSHi
dEHi
dt
= αmefffi
SHi
NHi
IV − (σH + µH)EHi
dI1Hi
dt
= σHEHi − (ϕH + ηH(Y ) + µH)I1Hi
dI2Hi
dt
= ϕHI1Hi − (γH(Y ) + µH)I2Hi
dRHi
dt
= ηH(Y )I1Hi + γH(Y )I2Hi − (ωH + µH)RHi
Tsetse

dPV
dt
= BVNH − (ξV + PVK )PV
dSV
dt
= ξV P(pupating)PV − αSV − µV SV
dE1V
dt
= α
(
1− fT (t)
)
pV
(∑
i fi
(I1Hi + I2Hi)
NHi
+ fA
IA
NA
)
(SV + εGV )
−(3σV + µV + αfT (t))E1V
dE2V
dt
= 3σV E1V − (3σV + µV + αfT (t))E2V
dE3V
dt
= 3σV E2V − (3σV + µV + αfT (t))E3V
dIV
dt
= 3σV E3V − (µV + αfT (t))IV
dGV
dt
= α(1− fT (t))SV
−α
(
fT (t) + (1− fT (t))pV ε
(∑
i fi
(I1Hi + I2Hi)
NHi
+ fA
IA
NA
)
GV
)
−µVGV
(1)
The actual number of vectors is SV , E1V , E2V , E3V , IV and GV multiplied by 174
NV /NH , where NV is the total population of adult tsetse and NH = NH1 +NH4 175
denotes the total human population. Then, the effective probability of human infection 176
per single infective tsetse bite meff is defined as NV pH/NH with the original 177
vector-to-human transmission probability pH . 178
Whilst the tsetse population size is assumed constant in almost all simulations 179
presented, we use an explicitly host-vector model to enable us to simulate the impact of 180
tsetse interventions. Vector control is included in Eq (1) as fT (t), the probability of a 181
fly both hitting a tiny target and subsequently dying at time t. The value of fT (t) is 182
dependent on the population reduction achieved by any vector control performed. For 183
Yasa Bonga health zone, the only health zone in which vector control took place prior to 184
the end of the data collection period, a 90% reduction in tsetse population in the first 185
year after biannual deployment of tiny targets was introduced [27]; more details are 186
given in the SI (S1 Materials and Methods) about the functional form of fT (t), which 187
was originally presented elsewhere [13]. Other tsetse parameters include the pupal stage 188
PV from which new, unfed (teneral) adult flies emerge and it is on this pupal class 189
where we place our density-dependent carrying capacity K, which governs the 190
bounceback speed of the population in the case where fT (t) 6= 0. Teneral flies, SV , are 191
considered susceptible to T. b. gambiense infection with probability pV on their first 192
blood meal, after this time the “teneral phenonmenon” results in previously fed flies, 193
November 13, 2020 10/25
GV , having reduced susceptibility to infection by a factor ε compared to unfed flies. 194
The proportion of tsetse bites taken on low-risk and high-risk humans are f1 and f4, 195
depending on the relative abundance and proximity of the two risk groups. If si is the 196
relative availability of host type i and high-risk humans are assumed to be r-fold more 197
likely to receive bites, then s1 = 1 and s4 = r. Therefore, fi’s can be calculated using 198
fi =
siNHi∑
j sjNHj
. 199
Improvements to passive case detection 200
For simulations in this study, we assumed that prior to 1998 there was limited passive 201
case detection, which would not detect stage 1 cases (ηpreH = 0) and have a slower time 202
to detection for stage 2 (γpreH = bγpreH × γ
post
H where bγpreH = [0, 1]). In 1998 we assume 203
that the introduction of the card agglutination test for trypanosomes (CATT) enabled 204
better diagnosis and stage 1 and 2 rates were increased to ηpostH and γ
post
H respectively. 205
As explored in a previous modelling study focusing on former Bandundu 206
province [16], there is strong evidence of improvements to the passive surveillance 207
system during 2000–2012 from examining the changes to the proportion of passive cases 208
identified in stage 1 compared to stage 2. The health-zone level data utilised here for 209
the main model fitting do not contain staging information before 2015 (and generally 210
there are relatively few cases in 2015 and 2016). The staged case information from 2015 211
and 2016 were aggregated to the former province level and used alongside the 212
provincial-level staged case data for 2000–2012 [28] to set prior distributions for logistic 213
functions which we use to describe improvements to both the passive stage 1 and stage 214
2 detection rates in each year: 215
ηH(Y ) = η
post
H
1 + ηHamp
1 + exp
(
−dsteep(Y − dchange)
)
 (2)
γH(Y ) = γ
post
H
1 + γHamp
1 + exp
(
−dsteep(Y − dchange)
)
 (3)
These functional forms were used in former Bandundu and Bas Congo provinces 216
where there was strong evidence of improvement in the data. In Bas Congo the “change 217
year”, dchange, was fixed to 2015.5 as this corresponds to the year in which there was a 218
substantial increase in the number of fixed health facilities with gHAT rapid diagnostic 219
tests (RDTs) [29]. 220
It is noted that only the stage 1 detection rate was changed in Model W in Castaño 221
et al. [16] as this provided a good fit to the data at the province level. Here we alter 222
both stage 1 and stage 2, firstly because it is logical that passive detection improvements 223
would lead to faster rates for both stages of disease, and secondly as this is better able 224
to capture passive detection patterns observed in health zone level data. In the present 225
study other provinces were assumed to have constant passive detection rates since 1998. 226
Active screening algorithms 227
Active screening since 2000 has generally comprised mobile teams screening as many 228
people as possible in villages using a multi-diagnostic algorithm. The first diagnostic 229
used is the CATT test on finger prick blood, and this may be followed by CATT 230
dilutions and finally microscopy to visually confirm presence of the parasite. After 231
parasite confirmation, the individual is a confirmed case and required further testing 232
using lumbar puncture to diagnose disease stage to be able to provide the correct 233
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stage-specific treatment. In the model we assume this algorithm has a sensitivity of 234
0.91, and very high but imperfect specificity with a prior around 0.9995 and fitted to 235
health zone level data. 236
Whilst the national programme, PNLTHA, have consistently used the algorithm 237
with parasitilogical confirmation, in former Oriental province in the North of the 238
country, some of the screening activities (pre-2013) were performed by MSF. The MSF 239
algorithm was more contracted and individuals who were found positive on a CATT 240
1:32 were reported as cases and given treatment. Therefore, a higher fixed sensitivity 241
(MSF sensitivity = 0.95 in contrast to PNLTHA sensitivity = 0.91) and a lower fitted 242
specificity (= bspecificity × specificity with targeted mean = 0.991, where 243
bspecificity = [0, 1]) are used for years up to 2012 in these regions. 244
Since 2015, video confirmation of parasitological diagnosis was introduced to 245
Mosango and Yasa Bonga health zones in former Bandundu province. This additional 246
validation diagnostic is designed to ensure quality control of case confirmation, which is 247
especially important as elimination is approached and very few cases remain. The 248
model uses the assumption that there have therefore been no false positives in active 249
screening since 2015 in Mosango and Yasa Bonga. 250
Vector control 251
Between 2000–2016 there were very limited vector control activities in DRC, with tsetse 252
control implemented in a single health zone, Yasa Bonga in former Bandundu province, 253
via the deployment of tiny targets since mid-2015. This method of control, using 254
insecticidal impregnanted blue targets, has successfully reduced fly populations in other 255
countries (90% in Uganda [30], 80% in Guinea, and 99% in Chad). In the present study 256
we incorporate vector control with a 90% reduction in tsetse for Yasa Bonga [27] (see SI 257
“S1 Materials and Methods” for further details). 258
Likelihood 259
Eight parameters; R0, r, η
post
H , γ
post
H , bγpreH , k1, u, and Spec were fitted in all health zones. 260
Additional parameters were included as required (combinations of dchange, ηHamp , γHamp , 261
dsteep and bspecificity as appropriate, see above). 262
The Metropolis-Hastings MCMC used a log-likelihood function:
LL(θ|x) = log(P (x|θ))
∝
2016∑
t=2000
(
log
[
BetaBin
(
AD1(t) +AD2(t); z(t),
AM1(t) +AM2(t)
z(t)
,dispact
)]
+ log
[
Bin
(
AD1(t);AD1(t) +AD2(t),
AM1(t)
AM1(t) +AM2(t)
)]
+ log
[
BetaBin
(
PD1(t) + PD2(t);NH ,
PM1(t) + PM2(t)
NH
,disppass
)]
+ log
[
Bin
(
PD1(t);PD1(t) + PD2(t),
PM1(t)
PM1(t) + PM2(t)
)])
The model takes parameterisation θ, x is the data, PDj(t) and ADj(t) are the 263
number of passive/active cases (of stage j) in year t of the data, PMj(t) and AMj(t) are 264
the number of passive/active cases (of stage j) in year t of the model, and z(t) is the 265
number of people screened in year t. BetaBin(m;n, p, ρ) gives the probability of 266
obtaining m successes out of n trials with probability p and overdispersion parameter ρ. 267
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The overdispersion accounts for larger variance than under the binomial. The pdf of 268
this distribution is given by: 269
BetaBin(m;n, p, ρ) =
Γ(n+ 1)Γ(m+ a)Γ(n−m+ b)Γ(a+ b)
Γ(n−m+ 1)Γ(n+ a+ b)Γ(a)Γ(b)
where a = p(1/ρ− 1) and b = a(1− p)/p. 270
Consequently larger ρ yield more overdispersion. To avoid overfitting, the 271
overdispersion parameters were left fixed at a value appropriate for a health zone level 272
fit across MCMC runs (Table 1). The value of ρ was chosen based on the median of the 273
log posterior probability distribution achieved from MCMC runs with ρ fixed at a range 274
of values for two example health zones. 275
For four health zones there was no screening reported in one or two years in which 276
there was more than 20 active cases recorded. In this scenario the number of negative 277
test results in year t, A−D(t), was sampled from a negative binomial distribution and 278
ẑ(i) = AD1(t) +AD2(t) +A
−
D(t) was used in the calculation of the log-likelihood in 279
place of zt. More detail is provided in the Supplementary Information (S1 Materials and 280
Methods). 281
Health zone results are aggregated by provinces and are compared to the province 282
level data as a check that the health zone fits make sense. 283
Priors 284
Prior distributions for the fitted parameters are given in Table 2 for the parameters 285
fitted in all health zones and those fitted in former Bandundu province. Information on 286
other former province–specific priors is given in the SI (S1 Materials and Methods). 287
Informative priors were used for most parameters. There was little information on 288
the stage of the disease in the data, essentially none before 2015. Former–province level 289
staged case numbers were available from 2000–2012 [28] and we augmented these with 290
our data aggregated to the former–province level for the years 2013 to 2016. The model 291
was fitted to these staged former–province level data and informative priors for the 292
parameters relating to treatment rates from stages 1 and 2 (ηpostH and γ
post
H ), and 293
improvement in passive detection (ηHamp , γHamp and dsteep) were based on the 294
respective posterior distributions from these analyses. 295
Markov chain Monte Carlo algorithm 296
For each health zone the model was fitted using the adaptive Metropolis-Hastings 297
random walk algorithm [31]. Two independent chains were run in parallel from different 298
starting values. The chains were run in 3 phases: a transient phase, an adaptive phase 299
and a sampling phase and only samples from the final phase were used in the analysis. 300
The aim of the transient phase was to move the chains towards the posterior mass. 301
In this phase, lasting B = 500 iterations, single site parameter updates were used with 302
proposal standard deviation σin for parameter i in proposal n. If proposal n was 303
accepted then σin+1 = 2σ
i
n and if it was rejected then σ
i
n+1 = 2
a/(a−1)σin. Here, we 304
target an acceptance rate of a = 0.44, which was found to be optimal in [32]. 305
The aim of the adaptive phase was to begin learning the covariance matrix of the
posterior in order to find an efficient proposal. In this phase proposals were drawn from
Y n+1 ∼ Nd(Xn, 2.38
2λ2n
d Σn), where Xn is the location of the chain after n iterations.
The covariance matrix was initially ΣB (the initial variances used can be found in the
parameter file which accompanies the code in the SI, “S6 Analysis Code”) and
subsequently
Σn+1 =
n−B
n−B + 10Cov(XB+1, . . . ,Xn) +
10
n−B + 10ΣB .
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The scaling factor was λn = 1 on even iterations and updated adaptively on odd 306
iterations, namely λn+2 = xnλn if iteration n was accepted and λn+2 = x
a/(a−1)
n λn if 307
rejected. We used xn = 1 +
50
50+n−B and targeted an acceptance rate of a = 23.4%, 308
which was found to be optimal in [32]. 309
The duration of the last two phases was determined adaptively, by examining the 310
Gelman-Rubin convergence diagnostic [33] and the Effective Sample Size (ESS) 311
diagnostic [34]. The adaptive phase was increased iteratively by 100 up to a maximum 312
of 105 iterations until the following convergence criteria were satisfied for the most 313
recent 2000 observations. First R
(i,j)
within < 1.1 for every parameter i and chain j; and 314
second R
(i)
between < 1.5 for all i. 315
Finally, in the sampling phase, proposals were drawn as for the adaptive phase. The 316
duration of this phase was determined based on ESS. To achieve a sample of 2,000 317
states with an ESS of at least 1,000, each chain was run for 1,000 iterations, thinned by 318
a factor κ = 1 and the ESS calculated to be twice the minimum ESS over the 319
parameters and the two chains. If the ESS criterion was not satisfied then a further 320
1,000 iterations were sampled from each chain and the thinning factor κ was increased 321
by 1, up to a maximum of 200. If the ESS criterion was still not satisfied then the 322
health zone was flagged for investigation. If an analysis finished with ESS ≤ 500 or 323
maxR
(i)
between ≥ 1.2 then that analysis was flagged for investigation, consisting of 324
manual appraisal of the joint posterior distributions and progress to convergence. None 325
of the analyses had maxR
(i)
between ≥ 1.2, and there was no evidence that those with 326
ESS ≤ 500 were not converging correctly. Additional sampling was carried out for all 327
analyses where ESS < 1, 000, allowing κ to exceed 200. 328
Results 329
Fig 4 shows the final maximum values of the Gelman-Rubin convergence diagnostic for 330
each health zone level analysis within former province. A good level of convergence was 331
achieved, with only 1 of 168 analyses having maxR
(i)
between > 1.02 while 149 of the 168 332
analyses had maxR
(i)
between ≤ 1.01. 333
The maximum number of iterations for the adaptive phase was required in 28 334
analyses. Of these, 18 were in the former province of Bandundu in which all health zone 335
analyses included fitting of additional parameters to account for changes in the 336
effectiveness of passive surveillance. It may be possible to improve the adaptive MCMC 337
to reduce the number of analyses carrying out the maximum adaptive phase length, 338
however the levels of convergence already achieved imply that the effort required may 339
not result in markedly improved analysis results. 340
The observed effective sample size (ESS) exceeded 1,000 in 140 of the individual 341
health zones analyses, and was less than 500 for 13 analyses. As with the adaptive 342
phase, 14 of 28 analyses with an ESS less than 1,000 were for health zones in Bandundu. 343
This again reflects the additional complexity of fitting the model in this former province. 344
The fitting process matches model outcomes to reported timeseries of actively- and 345
passively-detected cases. Fig 5 shows examples of these trends for two example health 346
zones; Kwamouth (in the former province of Bandundu) and Tandala (in the former 347
province of Equateur). Kwamouth has a much higher incidence of gHAT infection than 348
Tandala, and consequently has higher numbers of people being actively screened each 349
year – the average number of people actively screened annually in Kwamouth was 52% 350
of the estimated population in 2015 (127,205), while this was 6.8% for Tandala 351
(estimated 2015 population of 274,945). Fig 5 shows how well the model fits to the 352
timeseries of reported cases both actively and passively detected. In addition, Fig 5 also 353
shows the unobservable downward trend in new infections estimated by the model. The 354
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Fig 4. Maximum between-chain Gelman-Rubin convergence diagnostics for the final
posterior samples, grouped by former province and whether or not the maximum length
of adaptive phase (100,000 iterations) was reached.
results of all 168 health zone level fits including inferences about annual numbers of new 355
infections, are available online (S5 Online Results). 356
In Kwamouth health zone there is a noticeable “humped” trend in passive case 357
detection, with higher case reporting in 2005–2008. The model is able to replace this 358
trend by increasing the passive detection rates, ηH(Y ) and γH(Y ), and importantly we 359
infer that underlying transmission actually declines during this time period, despite 360
increased case reporting (see Fig 5 and S5 Online Results). This humped shape of 361
passive case reporting is observed in many health zones of former Bandundu province, 362
such as Bokoro, Bolobo, Ipamu, and Yasa Bonga. Much of former Equateur province 363
has a different typical pattern in its passive detection trend which looks similar to 364
exponential decay, especially in the north (e.g. Bominenge, Boto, Budjala, Gemena, 365
Karawa, Kungu, Libenge, Tandala) where there was very high case reporting in the 366
early 2000s. In these locations we reproduce the trend using fixed passive case detection 367
rates combined with successful active screening. 368
Table 3 contains former province-level estimates of the number of new infections in 369
2000, 2008 and 2016 and the percentage reduction in new infections between these years. 370
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The values from each of 1,000 posterior samples for each analysed health zone within a 371
former province were summed to give 1,000 former province–level values, each health 372
zone being independent in our analyses. Over this period, a 96% median reduction in 373
the number of new infections has been achieved in Equateur. The largest percentage 374
reductions in the number of new infections are seen in the former provinces with the 375
highest reported cases in 2000. Notably the province with the highest reporting in 2000 376
(Equateur), was not estimated to have the highest transmission (Bandundu was higher), 377
but does have a huge inferred reduction in transmission of 96%. Despite a calculated 378
89% transmission reduction, Bandundu province remained the province with most 379
ongoing transmission in 2016. 380
Table 3. Reduction in new gHAT infections by former province. Medians and 95% credible intervals (CIs) of aggregated
health zone-level outcomes.
Former province New infections (median [95% CI]) Percentage reduction
2000 2008 2016 2000–2008 2000–2016
Bandundu 7336 [6758,7929] 3186 [2917,3433] 801 [682,954] 57 [54,59] 89 [87,91]
Bas Congo 804 [721,891] 204 [181,231] 58 [45,76] 75 [72,77] 93 [90,94]
Equateur 4564 [4149,4978] 446 [405,490] 160 [136,190] 90 [89,91] 96 [96,97]
Kasai Occidental 700 [597,835] 313 [268,364] 163 [133,198] 55 [51,59] 77 [72,81]
Kasai Oriental 3534 [3232,3880] 1461 [1330,1623] 857 [746,1021] 59 [55,61] 76 [72,79]
Katanga 145 [109,193] 135 [102,178] 117 [85,161] 7 [-3,17] 20 [-1,37]
Kinshasa 238 [173,322] 135 [102,184] 85 [57,125] 43 [32,53] 64 [50,75]
Maniema 233 [191,285] 174 [147,209] 150 [121,186] 25 [17,34] 36 [22,49]
Orientale 2301 [2054,2550] 1528 [1324,1742] 739 [596,897] 33 [26,41] 68 [61,74]
The fits of the model to the reported case timeseries as exemplified in Fig 5 reflect 381
the parameters of the model, many of which are estimated within the fitting process. 382
Fig 6 illustrates the posterior distribution of R0 within each health zone for which 383
inference was performed. The map of DRC was partitioned into hexagons and partial 384
hexagons, based on health zone boundaries, which were then filled with a colour based 385
on a random value from the posterior distribution of R0 for that health zone. By 386
representing the posterior distributions in this way the aim is to illustrate how both the 387
level and variability of the parameter differs between health zones. The geographical 388
unit of interest here is the health zone and the locations of the hexagons within the 389
healthzone are meaningless. Further examples of this representation of posterior 390
distributions are available for the parameters fitted across all health zone analyses in 391
the supplementary information (S2 Posteriors of fitted parameters) and online (S5 392
Online Results). 393
The R0 posterior maps shows that some of the highest R0 estimates are in 394
Kwamouth health zone, former Bandundu province, although more generally R0 395
estimates remain very low - typically only slightly above one - for the whole country. R0 396
is a bundled parameter, linked to the ability of an infection to persist for a particular 397
geographic setting. Higher R0 values on the map roughly correspond to health zones 398
which have reported high number of cases historically. 399
Maps showing posterior passive detection rates (see ηpostH in SI; file S2, Fig S2.3) 400
show that there is geographic variability in time to detection, with typically quicker 401
diagnosis in 2000 in former Equateur province and slower times in former Orientale, 402
Maniema and Katanga. The average time that a person spent infectious, if not 403
identified by active screening, can be estimated in each health zone using the posterior 404
parameters (see S3 Using posteriors to infer time infected and reporting, section S3.1); 405
in Kwamouth health zone this duration changes from a median of 1224 days in 2000 to 406
813 days in 2016 and in Tandala this is fixed at 716 days between 2000 and 2016. 407
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Fig 5. Demonstration of fit to the observed trends in new case detection over time and
predicted numbers of new infections for two example health zones; Kwamouth in former
Bandundu province and Tandala in former Equateur province.
The specificity of the active screening diagnostic algorithm is computed to be very 408
high, with former Equateur province having near perfect specificity. The parameter u 409
corresponds to the proportion of cases that are reported if not picked up in active 410
screening. High u is interpreted as high reporting and fewer deaths outside the health 411
care system. Average reporting generally follows the prior of u although it appears that 412
former Equateur has better reporting (lower under-reporting/fewer deaths). The 413
estimated proportion of reporting including active screening can be computed using 414
model outputs for cases and deaths (see S3 Using posteriors to infer time infected and 415
reporting, section S3.2). In Kwamouth this is estimated to have changed from 0.67 416
(95%: 0.54–0.84) in 2000 to 0.82 (95%: 0.62–0.93) in 2016, while in Tandala it 417
fluctuated over time from 0.65 (95%: 0.53–0.75) in 2000 and finishing back at 0.65 (95%: 418
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0.0–1.0) in 2016, with the median varying between 0.40 (in 2010) and 0.76 (in 2003). 419
The low case numbers in later years are the cause of the higher uncertainty in the 420
percentage reporting in 2016. 421
Fig 6. Within health zone posterior distribution of R0. Fill colours for hexagons within
a health zone are determined by randomly sampled values from the posterior
distribution of R0 from the analysis of that health zone.
Discussion 422
The fitting process presented in this study enabled exploration of the underlying 423
epidemiology of gHAT at the health zone level, estimating parameters of the 424
transmission model based on historical data. The fits highlight the success of past 425
interventions, both in the obvious decline in the number of reported cases but also 426
through quantification of improvements in surveillance, such as in the case of changes in 427
passive surveillance over time in Bandundu and Bas Congo. 428
Even in areas where there has been a decline in active screening activity over time 429
(especially in former Equateur province where the mean annual screening from 430
2012–2016 was ∼150,000 compared to a maximum in 2003 of around 900,000), the 431
modelling indicates that there has been a real reduction in transmission (∼96% in 432
Equateur), rather than simply a decline in reported cases due to scaling back the 433
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detection effort. 434
We note that the health zone-level longitudinal case data typically did not have 435
staging information associated with them prior to 2015. The staging information for 436
2015 and 2016 were highly informative in quantifying passive detection improvements 437
when combined with provincial-level staged data published separately [28]. We reiterate 438
the recommendation of Castaño et al. [16], in collecting and digitising staged case data 439
whenever possible to enable continued assessment of the passive surveillance system. 440
The number and type of diagnostic tests used in passive surveillance would also be 441
valuable in assessing the effectiveness and activity levels of the passive surveillance 442
system. 443
There are other areas where additional data recording, either routine or as part of 444
systematic surveys could be beneficial. For example, the age and gender profile of gHAT 445
cases and populations screened would provide valuable information regarding high- and 446
low-risk groups of individuals, and potentially also their participation in screening. 447
Vector control activities are expanding in DRC. In the data used here, vector control 448
had only begun in 2015 in Yasa Bonga health zone and the model with respect to vector 449
control was parameterised using a fixed value for the reduction in tsetse population 450
taken from the entomological follow-up studies in this area. Incorporation of repeated 451
entomological survey data and human tsetse exposure data as in, for example, Courtin 452
et al. (2015) [35] may help the model be parameterised appropriately for each vector 453
control region, incorporating uncertainty about the vector control-related parameters. 454
In this study we have been able to estimate the relative vector-to-host ratio for 455
different regions through our adaptive MCMC. Maps of meff are shown in SI “S2 456
Posteriors of fitted parameters”, Fig S2.8, however these alone do not tell the whole 457
story and are not necessarily reflective of where one might find the highest density of 458
flies in DRC. In particular the high-/low-risk structure of the model (associated with 459
parameters k1, the proportion of the population who are low risk, and r the relative 460
exposure of high-risk individuals) is intimately entwined with the relative vector-to-host 461
ratio. It would, therefore, be possible in this framework to have a comparatively low 462
meff in a health zone, but high r due to dense pockets of tsetse habitat which only 463
high-risk people are exposed to; overall this could lead to a high burden health zone due 464
to population-level heterogeneity in risk. 465
Despite the complex nature of inferring the role of tsetse, we do examine a single 466
case where deliberate vector control has been deployed during the time period of our 467
dataset. In Yasa Bonga, tiny targets were used from 2015 and although it is not 468
strongly apparent by simply looking at case detections in 2016, we estimate that 469
transmission in the region has sharply fallen from around 22.6 (95% CI: 11.2–41.2) new 470
infections per year in 2015 to 1.3 (95% CI: 0.6–2.5) in 2016. Due to the slow progression 471
of the disease, it would be expected to take several years of case data until there is a 472
marked decline in both active and passive case detections. In future studies, more years 473
of human case and tsetse monitoring data from Yasa Bonga and other health zones, 474
which have subsequently begun tsetse control, will help to provide deeper insight into 475
the role of these vectors in transmission dynamics. 476
The model used here did not consider the presence of possible animal reservoirs or 477
transmission via asymptomatic humans. Historically, gHAT has been generally regarded 478
as an anthroponosis [36], lacking an animal reservoir which would hinder or prevent 479
elimination of the disease. More recently there have been concerns that this may not be 480
the case; T.b. gambiense has been identified in various animals, and have been shown to 481
be transmissible to tsetse experimentally [37]. Mathematical modelling has attempted 482
to ascertain the likelihood of animal transmission through various model comparison 483
exercises [6, 7], and also quantify relative transmission if it occurs. To date there is 484
inconclusive evidence, although declines in transmission due to medical intervention 485
November 13, 2020 19/25
over the last decades appear to rule out substantial animal transmission (see [38] for 486
more discussion on this topic). A more detailed analysis of the presence and/or role of 487
animal reservoirs is beyond the scope of the present study. 488
The gHAT model presented is an explicitly Ross-Macdonald-style, host-vector model 489
capable of simulating the impact of vector population size changes on transmission to 490
humans. This was introduced to enable the simulation of intentional vector control 491
which was deployed in Yasa Bonga health zone from 2015 and so that future modelling 492
using this framework could explore the possible impact of vector control in other 493
locations. We did not, however, consider other sources of fluctuation of tsetse 494
populations, although it is noted that anthropogenic change in particular could result in 495
loss of tsetse habitat and inadvertently reduce tsetse populations [39]. There are limited 496
data available on temporal changes in tsetse density across DRC to inform such an 497
analysis, however it could be a potential avenue for future research in areas of known 498
deforestation or urbanisation. 499
One published review [40] has previously suggested that the primary transmission 500
mechanism of gHAT is not tsetse. In the present modelling study, for the most part, it 501
would be unlikely to make any difference to our results to assume human-to-human 502
transmission as we assume stable vector populations which could be readily substituted 503
by a quasi-equilibrium assumption or even modelled as a contagion without substantial 504
quantitative differences. However, where vector control is implemented, our assumption 505
that gHAT is a vector-borne infection would produce very different results compared to 506
assuming no or limited tsetse transmission. This would be very pronounced if the model 507
is subsequently used to make projections of future vector control impact. We are 508
reassured by various other recent studies that our tsetse-transmission assumption is 509
valid as (i) the host-vector gHAT model predictions for regions with vector control 510
appear to match the case reductions well [7] and (ii) the natural experiment which 511
occurred in Guinea during the 2014–15 West African Ebola outbreak found that even 512
following interruption of medical screening activities, regions that had vector control 513
remaining in situ had much lower case burden following resumption of screening than 514
those without [41,42]. 515
The model framework utilised in the present study is deterministic, always yielding 516
the same outputs for the same set of input parameters – deterministic models can be 517
considered to represent expected average dynamics. Whilst we do address some 518
observational uncertainty through the overdispersion in the likelihood function and 519
drawing model case reporting outputs, the use of stochastic models which capture 520
chance events in transmission and reporting will become increasingly important as 521
infections approach zero. Other modelling studies utilising stochastic model 522
formulations have found that, even at low reported case numbers and for relatively 523
small populations (>2000 people), gHAT persists with high probability over long 524
periods [5]. At the health zone level (∼100,000 people) model dynamics follow closely to 525
deterministic ones until reaching extremely low case numbers [16]. We therefore consider 526
that the deterministic model fits presented here would be similar to those obtained using 527
a stochastic model variant in health zones with appreciable case reporting in the 2000s 528
and regular good-coverage active screening. In health zones with limited case detection 529
despite good screening coverage, a stochastic model would be more appropriate to 530
obtain robust model fits. Future analysis should consider how the adaptive MCMC 531
framework presented here could be built upon to fit stochastic model variants, especially 532
for fits at smaller geographic scales (e.g. health areas ∼10,000 people) are required. 533
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Conclusions 534
The gHAT model and automated adaptive MCMC approach presented here has 535
facilitated the fitting of longitudinal case data across the whole DRC for the first time. 536
The flexible framework will support future studies with straightforward fitting of other 537
model variants (such as those with animal reservoirs or asymptomatic human infection) 538
or to updated data sets in DRC or elsewhere. 539
The results of the fitting suggest that dwindling case reporting in many parts of the 540
country does correspond to a real reduction in underlying transmission, even in 541
locations where active screening coverage has also declined; Equateur province is a 542
prime example of this. The passive detection posterior parameters found for Bandundu 543
province indicate that substantial improvements have been made to reduce time to 544
detection in the region since the turn of the century - we are now able to quantify the 545
increase in the proportion of infections that are eventually reported rather than die 546
undiagnosed for each health zone. 547
These country-wide analyses have given an insight into why transmission may persist 548
in some locations more than others, for example the results indicate that passive 549
detection rates were higher in Equateur province in the early 2000s than in Bandundu 550
province and teamed with active screening this resulted in a more marked decline in 551
both cases and transmission. As well as interventions, epidemiological factors, including 552
human behaviour, are likely driving infection differences: the relative risk of high-risk 553
people compared to low-risk appears to be greater in known persistent regions of 554
Bandundu – including the health zones of Kwamouth, Bolobo, Mushie and Bagata – 555
compared to other provinces. 556
This finding raises the question of whether current medical-only interventions are 557
sufficient to reduce transmission to the point of interruption before 2030 in all regions, 558
or whether other approaches may be needed in locations with moderate but less 559
substantial reductions. Indeed, previous modelling for specific health zones in DRC has 560
suggested intensified interventions such as targeting high-risk groups in active screening 561
or vector control may be needed to speed up progress and meet the 2030 goal [13,15]. A 562
larger challenge is to identify where this may be needed across the country, and where 563
should be prioritised for bolstered interventions. 564
This study is a necessary first step towards providing modelling information which 565
can assist in the formulation of policy appropriate to the varying needs across the 566
country. Whilst beyond the scope of the present study, the fits obtained here may now 567
be used to simulate projections of the disease into the future under various different 568
interventions. Once forecasts have been made, the results can be used to examine 569
minimal strategies to achieve the 2030 elimination of transmission goal and economic 570
modelling can be used to ascertain location-specific, cost-effective options, refining more 571
general health economic analyses presented previously [43]. 572
Supplementary Information 573
S1 Materials and Methods More detailed description of materials and 574
methods. 575
S2 Posteriors of fitted parameters Additional results figures and tables. 576
Representations of posterior distributions of fitted parameters for the two example 577
health zones, across the country and within the former provinces of Bandundu and Bas 578
Congo. 579
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S3 Using posteriors to infer time infected and reporting Calculating the 580
average time spent infected and the proportion of infections that are reported. 581
S4 PRIME-NTD criteria Addressing the PRIME-NTD criteria for good modelling 582
practises. 583
S5 Online Results Results for each health zone level fit can be viewed at 584
https://hatmepp.warwick.ac.uk/fitting/v2/. 585
S6 Analysis Code Model code. The MATLAB code used to fit the model and 586
perform the adaptive MCMC is available from 587
https://doi.org/10.17605/osf.io/ck3tr. 588
S7 Posterior samples Posterior parameter sets. The health zone-specific 589
parameter sets obtained through this MCMC are available from 590
https://doi.org/10.17605/osf.io/ck3tr. 591
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